Anti-AKT (phospho T308) antibody (Ab38449)
PKB, RAC, AKT1, RAC-alpha serine/threonine-protein kinase, Protein kinase B, Protein kinase B alpha, Proto-oncogene c-Akt, RAC-PK-alpha, PKB alpha
详细信息
特异性
This antibody was made against a peptide directed against the phosphorylated form of AKT1 at T308, but due to a high degree of homology it is predicted to cross react with AKT2 and AKT3 if they are phosphorylated at the corresponding residue.
背景信息
Anti-AKT (phospho T308) antibody (ab38449) is a rabbit polyclonal antibody and is validated for use in IHC-P, WB in human, mouse, rat, recombinant fragment samples. Anti-AKT (phospho T308) antibody (Anti-RAC antibody; anti-pAKT antibody) (ab38449) has been cited over 779 times in peer reviewed journals and is trusted by the scientific community. Abcam's high quality validation processes ensure Anti-AKT (phospho T308) antibody (ab38449) has high sensitivity and specificity. Anti-AKT (phospho T308) antibody (ab38449) has 5 independent reviews from customers. Anti-AKT (phospho T308) antibody (ab38449) specifically detects AKT Phospho-T308 (UniProt ID: P31749; Molecular weight: 56kDa) and is sold in 100 µg selling sizes.
文献引用 (971)
Aminated fullerene-based nanoplatform enables synergistic VEGFR2-targeted anti-angiogenesis and tumor immunotherapy.
基于氨基化富勒烯的纳米平台可实现协同的 VEGFR2 靶向抗血管生成和肿瘤免疫治疗。
Nanozymes subvert pharmacological conventions: insights from counteracting the placental side effects of TiOâ nanozymes.
纳米酶颠覆药理学惯例：从对抗二氧化钛纳米酶的胎盘副作用中获得的启示。
Ipriflavone From Aquilaria malaccensis Lam. Exosome-Like Nanoparticles Targets Prolyl Hydroxylase Domain Protein 2 (PHD2) to Enhance Hypoxia-Inducible Factor-α (HIF-α) Hydroxylation Thereby Alleviating Hypoxia-Induced Gastrointestinal Mucosal Ferroptosis.
来自沉香属植物沉香的异丙黄酮外泌体样纳米颗粒靶向脯氨酰羟化酶结构域蛋白 2 (PHD2) 以增强缺氧诱导因子-α (HIF-α) 羟基化，从而缓解缺氧诱导的胃肠道粘膜铁死亡。
FBXO6 regulates colon cancer migration and invasion via ITGB1 ubiquitination and downstream signaling.
FBXO6 通过 ITGB1 泛素化和下游信号传导调节结肠癌细胞的迁移和侵袭。
ESM1 drives cancer angiogenesis and bevacizumab resistance via trioleate synthesis.
ESM1 通过三油酸酯合成驱动癌症血管生成和贝伐单抗耐药性。
DTX1-mediated degradation of TUBB3 in Kupffer cells mitigates hepatocellular carcinoma progression by regulating M1/M2 polarization
DTX1介导的库普弗细胞中TUBB3的降解通过调节M1/M2极化来减轻肝细胞癌的进展
FGFR2 is a Candidate Immune-Associated Marker of Diabetic Foot Ulcer That Promotes Keratinocyte Function by Activating the PI3K/Akt and MAPK Pathways.
FGFR2 是糖尿病足溃疡的候选免疫相关标志物，它通过激活 PI3K/Akt 和 MAPK 通路促进角质形成细胞功能。
Lactic Acid Drives ESM1 to Attenuate DNA Damage and CD8+ T Cell Infiltration in Cancer.
乳酸驱动 ESM1 减轻 DNA 损伤和 CD8+ T 细胞浸润到癌症中。
Targeted delivery and controlled release of deferasirox for melanoma therapy.
用于黑色素瘤治疗的去铁酮靶向递送和控释。
Combined Treatment with Shuyu Pills and Everolimus Suppresses Triple-Negative Breast Cancer Growth via the PI3K/AKT/mTOR Pathway.
舒郁丸与依维莫司联合治疗通过 PI3K/AKT/mTOR 通路抑制三阴性乳腺癌的生长。
- 1
- 2
- 3
- 4
- 5
- 6
- 98